Publication Cover
Orbit
The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery
Volume 38, 2019 - Issue 3
401
Views
14
CrossRef citations to date
0
Altmetric
Case Report

Pembrolizumab and epacadostat induced fatal myocarditis and myositis presenting as a case of ptosis and ophthalmoplegia

, &
Pages 244-247 | Received 13 Feb 2018, Accepted 13 Jun 2018, Published online: 09 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Filip Stefanovic, Andres Gomez-Caminero, David M Jacobs, Poornima Subramanian, Igor Puzanov, Maya R Chilbert, Steven G Feuerstein, Yan Yatsynovich, Benjamin Switzer & Jerome J Schentag. (2022) Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response. Clinical Pharmacology: Advances and Applications 14, pages 69-90.
Read now
Ruby A. Parikh, Benjamin C. Chaon & Meghan K. Berkenstock. (2021) Ocular Complications of Checkpoint Inhibitors and Immunotherapeutic Agents: A Case Series. Ocular Immunology and Inflammation 29:7-8, pages 1585-1590.
Read now
Caberry W Yu, Matthew Yau, Natalie Mezey, Ishraq Joarder & Jonathan A Micieli. (2020) Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review. Eye and Brain 12, pages 139-167.
Read now

Articles from other publishers (11)

R. Saad, A. Ghaddar & R. M. Zeenny. (2024) Pembrolizumab-induced myocarditis with complete atrioventricular block and concomitant myositis in a metastatic bladder cancer patient: a case report and review of the literature. Journal of Medical Case Reports 18:1.
Crossref
Abha Banerjee, Chandrakala Aluganti Narasimhulu & Dinender K. Singla. (2023) Immune interactions in pembrolizumab (PD-1 inhibitor) cancer therapy and cardiovascular complications. American Journal of Physiology-Heart and Circulatory Physiology 325:4, pages H751-H767.
Crossref
Elena Giovannini, Maria Paola Bonasoni, Michele D’Aleo, Ione Tamagnini, Matteo Tudini, Paolo Fais & Susi Pelotti. (2023) Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review. International Journal of Molecular Sciences 24:13, pages 10919.
Crossref
Liudmila Zotova. (2023) Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases. Diagnostics 13:7, pages 1243.
Crossref
A. Martens, P. P. Schauwvlieghe, A. Madoe, I. Casteels & S. Aspeslagh. (2023) Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Oliver Dugena, Chaolan Zheng, Jennifer Taylor & Annie Wong. (2022) Pembrolizumab-induced Myasthenia Gravis: Literature Review of Ocular Manifestations and a Refractory Case. Journal of Immunotherapy 45:6, pages 267-273.
Crossref
Naoki Hamada, Ayaka Maeda, Kaoru Takase-Minegishi, Yohei Kirino, Yumiko Sugiyama, Ho Namkoong, Nobuyuki Horita, Ryusuke Yoshimi & Hideaki Nakajima. (2021) Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis. Frontiers in Immunology 12.
Crossref
Ranjan Pathak, Anjan Katel, Erminia Massarelli, Victoria M Villaflor, Virginia Sun & Ravi Salgia. (2021) Immune Checkpoint Inhibitor–Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases. The Oncologist 26:12, pages 1052-1061.
Crossref
Hotaka Matsui, Taketo Kawai, Yusuke Sato, Junichi Ishida, Hiroshi Kadowaki, Yoshiyuki Akiyama, Yuta Yamada, Masaki Nakamura, Daisuke Yamada, Hiroshi Akazawa, Motofumi Suzuki, Issei Komuro & Haruki Kume. (2020) A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma. International Heart Journal 61:5, pages 1070-1074.
Crossref
Vivian Paraskevi Douglas, Konstantinos A.A. Douglas & Dean M. Cestari. (2019) Immune checkpoint inhibitors. Current Opinion in Ophthalmology 30:6, pages 426-433.
Crossref
. (2019) Epacadostat/pembrolizumab. Reactions Weekly 1764:1, pages 126-126.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.